Literature DB >> 25280896

Chromatin-driven behavior of topologically associating domains.

Filippo Ciabrelli1, Giacomo Cavalli2.   

Abstract

Metazoan genomes are highly organized inside the cell nucleus. Topologically associating domains (TADs) represent the building blocks of genome organization, but their linear modularity does not explain alone their spatial organization. Indeed, the chromatin type adorning a TAD can shape its structure and drives its nuclear positioning and its function. Genome-wide association studies revealed mainly four chromatin types: active chromatin, Polycomb-repressed chromatin, null chromatin and constitutive heterochromatin. In this review, we will describe the main three-dimensional features of each chromatin type and finally their relationships with TAD organization and epigenetic memory.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  3D chromosome organization; Polycomb; chromatin; genome regulation; topologically associating domains

Mesh:

Substances:

Year:  2014        PMID: 25280896     DOI: 10.1016/j.jmb.2014.09.013

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  47 in total

Review 1.  Coming to terms with chromatin structure.

Authors:  Liron Even-Faitelson; Vahideh Hassan-Zadeh; Zahra Baghestani; David P Bazett-Jones
Journal:  Chromosoma       Date:  2015-07-30       Impact factor: 4.316

2.  A single three-dimensional chromatin compartment in amphioxus indicates a stepwise evolution of vertebrate Hox bimodal regulation.

Authors:  Rafael D Acemel; Juan J Tena; Ibai Irastorza-Azcarate; Ferdinand Marlétaz; Carlos Gómez-Marín; Elisa de la Calle-Mustienes; Stéphanie Bertrand; Sergio G Diaz; Daniel Aldea; Jean-Marc Aury; Sophie Mangenot; Peter W H Holland; Damien P Devos; Ignacio Maeso; Hector Escrivá; José Luis Gómez-Skarmeta
Journal:  Nat Genet       Date:  2016-02-01       Impact factor: 38.330

3.  Changes in Gene Expression and Estrogen Receptor Cistrome in Mouse Liver Upon Acute E2 Treatment.

Authors:  Gaëlle Palierne; Aurélie Fabre; Romain Solinhac; Christine Le Péron; Stéphane Avner; Françoise Lenfant; Coralie Fontaine; Gilles Salbert; Gilles Flouriot; Jean-François Arnal; Raphaël Métivier
Journal:  Mol Endocrinol       Date:  2016-05-10

Review 4.  Eukaryotic enhancers: common features, regulation, and participation in diseases.

Authors:  Maksim Erokhin; Yegor Vassetzky; Pavel Georgiev; Darya Chetverina
Journal:  Cell Mol Life Sci       Date:  2015-02-26       Impact factor: 9.261

Review 5.  Advances in Chromatin Imaging at Kilobase-Scale Resolution.

Authors:  Alistair Boettiger; Sedona Murphy
Journal:  Trends Genet       Date:  2020-01-29       Impact factor: 11.639

6.  Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

Authors:  S T Narla; Y-W Lee; C A Benson; P Sarder; K J Brennand; E K Stachowiak; M K Stachowiak
Journal:  Schizophr Res       Date:  2017-01-13       Impact factor: 4.939

7.  The TAD-pathway for GWAS signals.

Authors:  Natalia Pervjakova; Inga Prokopenko
Journal:  Eur J Hum Genet       Date:  2017-11       Impact factor: 4.246

Review 8.  Boundaries of loop domains (insulators): Determinants of chromosome form and function in multicellular eukaryotes.

Authors:  Darya Chetverina; Miki Fujioka; Maksim Erokhin; Pavel Georgiev; James B Jaynes; Paul Schedl
Journal:  Bioessays       Date:  2017-01-30       Impact factor: 4.345

9.  A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping.

Authors:  Suhas S P Rao; Miriam H Huntley; Neva C Durand; Elena K Stamenova; Ivan D Bochkov; James T Robinson; Adrian L Sanborn; Ido Machol; Arina D Omer; Eric S Lander; Erez Lieberman Aiden
Journal:  Cell       Date:  2014-12-11       Impact factor: 41.582

10.  Barcelona conference on epigenetics and cancer 2015: Coding and non-coding functions of the genome.

Authors:  David Corujo; Gloria Mas; Roberto Malinverni; Luciano Di Croce; Marcus Buschbeck
Journal:  Epigenetics       Date:  2016       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.